BAX vs. EW
Compare and contrast key facts about Baxter International Inc. (BAX) and Edwards Lifesciences Corporation (EW).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BAX or EW.
Correlation
The correlation between BAX and EW is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BAX vs. EW - Performance Comparison
Loading data...
Key characteristics
BAX:
-0.26
EW:
-0.33
BAX:
-0.16
EW:
-0.09
BAX:
0.98
EW:
0.98
BAX:
-0.13
EW:
-0.22
BAX:
-0.54
EW:
-0.53
BAX:
15.56%
EW:
22.89%
BAX:
32.59%
EW:
41.38%
BAX:
-68.86%
EW:
-54.32%
BAX:
-62.48%
EW:
-42.76%
Fundamentals
BAX:
$16.36B
EW:
$43.88B
BAX:
-$0.52
EW:
$2.42
BAX:
2.00
EW:
4.11
BAX:
1.52
EW:
7.95
BAX:
2.24
EW:
4.27
BAX:
$11.89B
EW:
$5.54B
BAX:
$4.28B
EW:
$4.39B
BAX:
$214.00M
EW:
$1.77B
Returns By Period
In the year-to-date period, BAX achieves a 9.86% return, which is significantly higher than EW's 1.04% return. Over the past 10 years, BAX has underperformed EW with an annualized return of -0.13%, while EW has yielded a comparatively higher 13.11% annualized return.
BAX
9.86%
14.51%
-5.90%
-8.29%
-16.27%
-0.13%
EW
1.04%
7.78%
12.14%
-13.75%
0.95%
13.11%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BAX vs. EW — Risk-Adjusted Performance Rank
BAX
EW
BAX vs. EW - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Baxter International Inc. (BAX) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
BAX vs. EW - Dividend Comparison
BAX's dividend yield for the trailing twelve months is around 2.89%, while EW has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BAX Baxter International Inc. | 2.89% | 3.57% | 3.00% | 2.26% | 1.27% | 1.21% | 1.02% | 1.11% | 0.94% | 1.14% | 0.60% | 0.00% |
EW Edwards Lifesciences Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
BAX vs. EW - Drawdown Comparison
The maximum BAX drawdown since its inception was -68.86%, which is greater than EW's maximum drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for BAX and EW. For additional features, visit the drawdowns tool.
Loading data...
Volatility
BAX vs. EW - Volatility Comparison
Baxter International Inc. (BAX) and Edwards Lifesciences Corporation (EW) have volatilities of 8.33% and 8.38%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
BAX vs. EW - Financials Comparison
This section allows you to compare key financial metrics between Baxter International Inc. and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BAX vs. EW - Profitability Comparison
BAX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Baxter International Inc. reported a gross profit of 861.00M and revenue of 2.63B. Therefore, the gross margin over that period was 32.8%.
EW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Edwards Lifesciences Corporation reported a gross profit of 1.11B and revenue of 1.41B. Therefore, the gross margin over that period was 78.8%.
BAX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Baxter International Inc. reported an operating income of -40.00M and revenue of 2.63B, resulting in an operating margin of -1.5%.
EW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Edwards Lifesciences Corporation reported an operating income of 409.90M and revenue of 1.41B, resulting in an operating margin of 29.0%.
BAX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Baxter International Inc. reported a net income of 320.00M and revenue of 2.63B, resulting in a net margin of 12.2%.
EW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Edwards Lifesciences Corporation reported a net income of 358.00M and revenue of 1.41B, resulting in a net margin of 25.3%.